Yayınlar | Prof. Dr. Yaman Tokat

  1. Andacoglu O, Tokat Y, Malamutmann E, Adali G, Emre A, Oezcelik A. Outcomes of right lobe donors with BMI≥30 for living donor liver transplantation. Clin Transplant. 2022 Jul;36(7):e14698. doi: 10.1111/ctr.14698. Epub 2022 Jun 8. PMID: 35561085.
  2. Andacoglu O, Sabisch E, Malamutmann E, Ozbek U, Emre A, Tokat Y, Oezcelik A. Multi-center living liver donor quality of life survey up to 20 years after donor hepatectomy and association with surgical outcomes. HPB (Oxford). 2022 Jun 24:S1365-182X(22)01507-6. doi: 10.1016/j.hpb.2022.06.007. Epub ahead of print. PMID: 35817693.
  3. Goldaracena N, Bhangui P, Yoon YI, Vargas PA, Spiro M, Raptis DA, Tokat Y; ERAS4OLT.org Working Group. Early removal of drains and lines after liver transplantation to reduce the length of hospital stay and enhance recovery - A systematic review of the literature and expert panel recommendations. Clin Transplant. 2022 Apr 25:e14687. doi: 10.1111/ctr.14687. Epub ahead of print. PMID: 35468235.
  4. Sarıgöl Ordin Y, Harmancı Seren AK, Karayurt Ö, Aksu Kul G, Kılıç M, Bozoklar CA, Tokat Y. Evaluation of Psychosocial Outcomes of Living Liver Donors in Liver Transplantation. Turk J Gastroenterol. 2022 Apr;33(4):346-355. doi: 10.5152/tjg.2022.21262. PMID: 35550542; PMCID: PMC9153957.
  5. Çelebi F, Görmez A, Ilgun AS, Tokat Y, Balcı NC. The value of 18F-FDG PET/MRI in prediction of microvascular invasion in hepatocellular carcinoma. Eur J Radiol. 2022 Apr;149:110196. doi: 10.1016/j.ejrad.2022.110196. Epub 2022 Feb 4. PMID: 35144118.
  6. Alim A, Erdogan Y, Dayangac M, Yuzer Y, Tokat Y, Oezcelik A. Normal Primary Graft Function Despite Early Hepatic Artery Thrombosis After Living-Donor Liver Transplant. Exp Clin Transplant. 2022 Mar;20(3):293-298. doi: 10.6002/ect.2017.0363. Epub 2018 Oct 19. PMID: 30346266.
  7. Heinemann M, Liwinski T, Adam R, Berenguer M, Mirza D, Malek-Hosseini SA, Heneghan MA, Lodge P, Pratschke J, Boudjema K, Paul A, Zieniewicz K, Fronek J, Mehrabi A, Acarli K, Tokat Y, Coker A, Yilmaz S, Karam V, Duvoux C, Lohse AW, Schramm C; all the other contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA). Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry. Am J Transplant. 2022 Feb;22(2):626-633. doi: 10.1111/ajt.16864. Epub 2021 Oct 21. PMID: 34605157.
  8. Jaradat D, Bagias G, Lorf T, Tokat Y, Obed A, Oezcelik A. Liver transplantation for combined hepatocellular-cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis. Clin Transplant. 2021 Feb;35(2):e14094. doi: 10.1111/ctr.14094. Epub 2021 Jan 15. PMID: 32970878.
  9. Çelebi F, Yaghouti K, Cindil E, Dogusoy GB, Tokat Y, Balcı C. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms. Acad Radiol. 2021 Feb;28(2):189-198. doi: 10.1016/j.acra.2020.01.026. Epub 2020 Feb 25. PMID: 32111468.
  10. Alim A, Erdogan Y, Dayangac M, Yuzer Y, Tokat Y, Oezcelik A. Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria. Cancer Control. 2021 Jan-Dec;28:10732748211011960. doi: 10.1177/10732748211011960. PMID: 33926242; PMCID: PMC8204628.
  11. Alim A, Dayangac M, Erdogan Y, Malamutmann E, Yuzer Y, Tokat Y, Oezcelik A. Splenic Artery Transposition for Arterial Reconstruction in Living Donor Liver Transplantation. Transplant Proc. 2021 Jan-Feb;53(1):36-41. doi: 10.1016/j.transproceed.2020.02.155. Epub 2020 Jun 4. PMID: 32505498.
  12. Acar Ş, Akyıldız M, Gürakar A, Tokat Y, Dayangaç M. Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation. Turk J Gastroenterol. 2020 Nov;31(11):782-789. doi: 10.5152/tjg.2020.18761. PMID: 33361041; PMCID: PMC7759225.
  13. Zidan, A.; Alabbad, S.; Ali, T.; Nizami, I.; Haberal, M.; Tokat, Y.; Kamel, R.; Said, H.; Abdelaal, A.; Elsharkawy, M.; El Fouly, A.; Sayed, H.; Al-Mousawi, M.; AlGhonaim, M.; Broering, D. Position Statement of Transplant Activity in the Middle East in Era of COVID-19 Pandemic. Transplantation 2020, 104 (11), 2205–2207. https://doi.org/10.1097/TP.0000000000003348.
  14. Jaradat, D.; Bagias, G.; Lorf, T.; Tokat, Y.; Obed, A.; Oezcelik, A. Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: Outcomes and Prognostic Factors for Mortality. A Multicenter Analysis. Clin Transplant 2020, e14094. https://doi.org/10.1111/ctr.14094.
  15. Akyildiz, M.; Gungor, G.; Guler, N.; Acar, S.; Erdogan, Y.; Gencdal, G.; Dayangaç, M.; Tokat, Y. Adult Living Donor Liver Transplantation from Donors with Gilbert’s Syndrome: Is It Safe? Clin Transplant 2020, 34 (9), e14015. https://doi.org/10.1111/ctr.14015.
  16. Alim, A.; Dayangac, M.; Erdogan, Y.; Malamutmann, E.; Yuzer, Y.; Tokat, Y.; Oezcelik, A. Splenic Artery Transposition for Arterial Reconstruction in Living Donor Liver Transplantation. Transplant Proc 2020. https://doi.org/10.1016/j.transproceed.2020.02.155.
  17. Canbolat, İ. P.; Akdeniz, C.; Ferah, O.; Tokat, Y. Post-Operative N-Terminal pro-Brain Natriuretic Peptide Predicts in-Hospital Mortality after Living Donor Liver Transplantation. Turk Kardiyol Dern Ars 2020, 48 (4), 374–379. https://doi.org/10.5543/tkda.2020.42637.
  18. Çelebi, F.; Yaghouti, K.; Cindil, E.; Dogusoy, G. B.; Tokat, Y.; Balcı, C. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms. Acad Radiol 2020. https://doi.org/10.1016/j.acra.2020.01.026.
  19. Çabuk, F.; Başsüllü, N.; Türkmen, İ.; Dayangaç, M.; Akyıldız, M.; Yüzer, Y.; Tokat, Y.; Doğusoy, G. The Prognostic Relationship between Histopathological and Immunohistochemical Features of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma and Mixed Type. Pol J Pathol 2020, 71 (2), 79–86. https://doi.org/10.5114/pjp.2020.97015.
  20. Alim, A.; Malamutmann, E.; Dayangac, M.; Erdogan, Y.; Gokakin, A. K.; Tokat, Y.; Oezcelik, A. Comorbidity Index as a Selection Tool for Living Donor Liver Transplantation in Elderly Patients. Transplant Proc 2019, 51 (10), 3315–3319. https://doi.org/10.1016/j.transproceed.2019.07.030.
  21. Petrowsky, H.; Kim, K.-H.; Tokat, Y. Editorial: Living-Donor Liver Transplantation: Why the Sun Rises in the East and Sets in the West? Curr Opin Organ Transplant 2019, 24 (5), 620–622. https://doi.org/10.1097/MOT.0000000000000700.
  22. Tokat, Y.; Balci, D. First International Transplant Network Congress. Transplant Proc 2019, 51 (7), 2153. https://doi.org/10.1016/j.transproceed.2019.07.002.
  23. Server, S.; Sabet, S.; Sahin, T.; Guven, K.; Aydın, U.; Tokat, Y.; Inan, N. Novel Application of Internal-External Drainage Catheter as Biliary Stent for Percutaneous Transhepatic Treatment of Biliary Strictures in Living Donor Liver Transplantation Recipient Patients. Transplant Proc 2019, 51 (7), 2469–2472. https://doi.org/10.1016/j.transproceed.2019.01.153.
  24. Server, S.; Sabet, S.; Bilgin, R.; Inan, N.; Yuzer, Y.; Tokat, Y. Intravoxel Incoherent Motion Parameters for Assessing the Efficiency of Locoregional Bridging Treatments before Liver Transplantation. Transplant Proc 2019, 51 (7), 2391–2396. https://doi.org/10.1016/j.transproceed.2019.01.161.
  25. Server, S.; Sabet, S.; Yaghouti, K.; Namal, E.; Inan, N.; Tokat, Y. Value of Imaging Findings in the Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Transplant Proc 2019, 51 (7), 2403–2407. https://doi.org/10.1016/j.transproceed.2019.01.178.
  26. Serin, A.; Tokat, Y. Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease. Transplant Proc 2019, 51 (7), 2457–2460. https://doi.org/10.1016/j.transproceed.2019.01.163.
  27. Serin, A.; Sahin, T.; Emek, E.; Arikan, T.; Koculu, S.; Yazici, P.; Mammadov, E.; Yuzer, Y.; Tokat, Y. Role of Preoperative Viral Load and Presence of Hepatocellular Carcinoma in the Biliary Complications After Liver Transplantation Due to Hepatitis C Virus. Transplant Proc 2019, 51 (7), 2482–2485. https://doi.org/10.1016/j.transproceed.2019.02.043.
  28. Serin, A.; Sahin, T.; Arikan, B. T.; Emek, E.; Bozkurt, B.; Tokat, Y. A Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey. Transplant Proc 2019, 51 (7), 2416–2419. https://doi.org/10.1016/j.transproceed.2019.01.190.
  29. Sahin, T.; Serin, A.; Emek, E.; Bozkurt, B.; Arikan, B. T.; Tokat, Y. Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis. Transplant Proc 2019, 51 (7), 2397–2402. https://doi.org/10.1016/j.transproceed.2019.01.193.
  30. Sahin, T.; Arikan, B. T.; Serin, A.; Emek, E.; Bozkurt, B.; Server, S.; Dibekoglu, C.; Tokat, Y. The Utility of Noninvasive Scoring Systems for Prediction of Hepatic Steatosis in Liver Transplantation Donor Candidates. Transplant Proc 2019, 51 (7), 2383–2386. https://doi.org/10.1016/j.transproceed.2019.01.177.
  31. Ferah, O.; Akbulut, A.; Açık, M. E.; Gökkaya, Z.; Acar, U.; Yenidünya, Ö.; Yentür, E.; Tokat, Y. Scoring Systems and Postoperative Outcomes in Pediatric Liver Transplantation. Transplant Proc 2019, 51 (7), 2430–2433. https://doi.org/10.1016/j.transproceed.2019.01.174.
  32. Ferah, O.; Akbulut, A.; Açik, M. E.; Gökkaya, Z.; Acar, U.; Yenidünya, Ö.; Yentür, E.; Tokat, Y. Acute Kidney Injury After Pediatric Liver Transplantation. Transplant Proc 2019, 51 (7), 2486–2491. https://doi.org/10.1016/j.transproceed.2019.01.179.
  33. Emek, E.; Yesim Kara, Z.; Demircan, F. H.; Serin, A.; Yazici, P.; Sahin, T.; Tokat, Y.; Bozkurt, B. Analysis of the Liver Transplant Waiting List in Our Center. Transplant Proc 2019, 51 (7), 2413–2415. https://doi.org/10.1016/j.transproceed.2019.01.192.
  34. Emek, E.; Serin, A.; Sahin, T.; Yazici, P.; Yuzer, Y.; Tokat, Y.; Bozkurt, B. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience. Transplant Proc 2019, 51 (7), 2439–2441. https://doi.org/10.1016/j.transproceed.2019.01.156.
  35. Canbolat, I. P.; Adali, G.; Akdeniz, C. S.; Bozkurt, B.; Ferah, O.; Bulutcu, F.; Yuzer, Y.; Tokat, Y. Postoperative Myocardial Injury Does Not Predict Early and 1-Year Mortality After Living Donor Liver Transplantation. Transplant Proc 2019, 51 (7), 2478–2481. https://doi.org/10.1016/j.transproceed.2019.02.046.
  36. Bozkurt, B.; Emek, E.; Arikan, T.; Ceyhan, O.; Yazici, P.; Sahin, T.; Mammadov, E.; Serin, A.; Gurcan, N. I.; Yuzer, Y.; Tokat, Y. Liver Graft Volume Estimation by Manual Volumetry and Software-Aided Interactive Volumetry: Which Is Better? Transplant Proc 2019, 51 (7), 2387–2390. https://doi.org/10.1016/j.transproceed.2019.01.152.
  37. Arikan, T.; Emek, E.; Bozkurt, B.; Mammadov, E.; Ceyhan, O.; Sahin, T.; Dibekoglu, C.; Serin, A.; Aydin, U.; Tokat, Y. Does Multiple Bile Duct Anastomosis in Living Donor Liver Transplantation Affect the Postoperative Biliary Complications? Transplant Proc 2019, 51 (7), 2473–2477. https://doi.org/10.1016/j.transproceed.2019.01.160.
  38. Arikan, T.; Mammadov, E.; Emek, E.; Bozkurt, B.; Inan Gurcan, N.; Yazici, P.; Sahin, T.; Serin, A.; Aydin, U.; Tokat, Y. Utility of Polyethylene Terephthalate (Dacron) Vascular Grafts for Venous Outflow Reconstruction in Living-Donor Liver Transplantations. Transplant Proc 2019, 51 (7), 2442–2445. https://doi.org/10.1016/j.transproceed.2019.02.040.
  39. Adalı, G.; Bozkurt, B.; Ceyhan, Ö.; Server, S.; Doğusoy, G. B.; Yüzer, Y.; Tokat, Y. Body Mass Index and Unenhanced CT as a Predictor of Hepatic Steatosis in Potential  Liver Donors. Transplant Proc 2019, 51 (7), 2373–2378. https://doi.org/10.1016/j.transproceed.2019.02.047.
  40. Acar, U.; Gökkaya, Z.; Akbulut, A.; Ferah, O.; Yenidünya, Ö.; Açık, M. E.; Tokat, Y.; Yentür, E. Impact of Cytokine Adsorption Treatment in Liver Failure. Transplant Proc 2019, 51 (7), 2420–2424. https://doi.org/10.1016/j.transproceed.2019.01.167.
  41. Sokmen, B. K.; Sabet, S.; Oz, A.; Server, S.; Namal, E.; Dayangac, M.; Dogusoy, G. B.; Tokat, Y.; Inan, N. Value of Intravoxel Incoherent Motion for Hepatocellular Carcinoma Grading. Transplant Proc 2019, 51 (6), 1861–1866. https://doi.org/10.1016/j.transproceed.2019.02.027.
  42. Haldar, D.; Kern, B.; Hodson, J.; Armstrong, M. J.; Adam, R.; Berlakovich, G.; Fritz, J.; Feurstein, B.; Popp, W.; Karam, V.; Muiesan, P.; O’Grady, J.; Jamieson, N.; Wigmore, S. J.; Pirenne, J.; Malek-Hosseini, S. A.; Hidalgo, E.; Tokat, Y. et al. Outcomes of Liver Transplantation for Non-Alcoholic Steatohepatitis: A European Liver Transplant Registry Study. J Hepatol 2019, 71 (2), 313–322. https://doi.org/10.1016/j.jhep.2019.04.011.
  43. Suner, A.; Carr, B. I.; Akkiz, H.; Uskudar, O.; Kuran, S.; Tokat, Y.; Tokmak, S.; Ballı, T.; Ulku, A et al. Inflammatory Markers C-Reactive Protein and PLR in Relation to HCC Characteristics. J Transl Sci 2019, 5 (3). https://doi.org/10.15761/JTS.1000260.
  44. Tsochatzis, E.; Coilly, A.; Nadalin, S.; Levistky, J.; Tokat, Y.; Ghobrial, M.; Klinck, J.; Berenguer, M. International Liver Transplantation Consensus Statement on End-Stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation. Transplantation 2019, 103 (1), 45–56. https://doi.org/10.1097/TP.0000000000002433.
  45. Suner, A.; Carr, B. I.; Akkiz, H.; Karakülah, G.; Üsküdar, O.; Yalçın, K.; Kuran, S.; Tokat, Y. et al. C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma. Oncology 2019, 96 (1), 25–32. https://doi.org/10.1159/000492473.
  46. Alim, A.; Erdogan, Y.; Dayangac, M.; Yuzer, Y.; Tokat, Y.; Oezcelik, A. Normal Primary Graft Function Despite Early Hepatic Artery Thrombosis After Living-Donor Liver Transplant. Exp Clin Transplant 2018. https://doi.org/10.6002/ect.2017.0363.
  47. Öz, A.; Koyuncu Sökmen, B.; İnan, N.; Balcı, N. C.; Tokat, Y. Incidentally Detected PET-Avid Liver Adenomatosis: MRI and 18F-FDG PET-CT Findings. Turk J Gastroenterol 2018, 29 (5), 623–624. https://doi.org/10.5152/tjg.2018.18105.
  48. Aumann, E. K.; Server, S.; Koyuncu Sokmen, B.; Oz, A.; Namal, E.; Gurcan, N. I.; Balci, N. C.; Tokat, Y. Diagnostic Performances of Intravoxel Incoherent Motion and Conventional Diffusion-Weighted Imaging in the Differential Diagnosis of Benign and Malignant Portal Vein Thrombus. Abdom Radiol (NY) 2018, 43 (9), 2270–2276. https://doi.org/10.1007/s00261-018-1467-6.
  49. Carr, B. I.; Akkiz, H.; Üsküdar, O.; Yalçın, K.; Guerra, V.; Kuran, S.; Karaoğullarından, Ü.; Altıntaş, E.; Özakyol, A.; Tokmak, S.; Ballı, T.; Yücesoy, M.; Bahçeci, H. İ.; Ülkü, A.; Akçam, T.; Polat, K. Y.; Ekinci, N.; Şimşek, H.; Örmeci, N.; Sonsuz, A.; Demir, M.; Kılıç, M.; Uygun, A.; Demir, A.; Delik, A.; Arslan, B.; Doran, F.; Yilmaz, S.; Tokat, Y. HCC with Low- and Normal-Serum Alpha-Fetoprotein Levels. Clin Pract (Lond) 2018, 15 (1), 453–464. https://doi.org/10.4172/clinical-practice.1000393.
  50. Carr, B. I.; Akkiz, H.; Guerra, V.; Üsküdar, O.; Kuran, S.; Karaoğullarından, Ü.; Tokmak, S.; Ballı, T.; Ülkü, A.; Akçam, T.; Delik, A.; Arslan, B.; Doran, F.; Yalçın, K.; Altntaş, E.; Özakyol, A.; Yücesoy, M.; Bahçeci, H. İ.; Polat, K. Y.; Ekinci, N.; Şimşek, H.; Örmeci, N.; Sonsuz, A.; Demir, M.; Kılıç, M.; Uygun, A.; Demir, A.; Yilmaz, S.; Tokat, Y. C-Reactive Protein and Hepatocellular Carcinoma: Analysis of Its Relationships to  Tumor Factors. Clin Pract (Lond) 2018, 15 (Spec Issue), 625–634. https://doi.org/10.4172/clinical-practice.1000409.
  51. Canbolat, I. P.; Erdogan, Y.; Adali, G.; Kaplan, O.; Dayangac, M.; Yuzer, Y.; Tokat, Y. The Predictive Value of Risk Indices for Cardiac Complications in Living Donor Liver Transplantation. Bratisl Lek Listy 2018, 119 (5), 289–293. https://doi.org/10.4149/BLL_2018_054.
  52. Akkiz, H.; Carr, B. I.; Kuran, S.; Karaoğullarından, Ü.; Üsküdar, O.; Tokmak, S.; Arslan, B.; Doran, F.; Balli, H. T.; Ülkü, A.; Akçam, T. A.; Bahçeci, H. İ.; Polat, K. Y.; Örmeci, N.; Şimşek, H.; Sonsuz, A.; Demir, A.; Altıntaş, E.; Demir, M.; Yalçın, K.; Ekinci, N.; Harmancı Özakyol, A.; Yücesoy, M.; Uygun, A.; Guerra, V.; Delik, A.; Tokat, Y.; Yilmaz, S.; Bektaş, A.; Kılıç, M. Macroscopic Portal Vein Thrombosis in HCC Patients. Can J Gastroenterol Hepatol 2018, 2018, 3120185. https://doi.org/10.1155/2018/3120185.
  53. Acar, Ş.; Güngör, G.; Dayangaç, M.; Diz-Küçükkaya, R.; Tokat, Y.; Akyıldız, M. Liver Transplantation in a Patient with Acquired Dysfibrinogenemia Who Presented with Subdural Hematoma: A Case Report. Turk J Haematol 2017, 34 (4), 356–357. https://doi.org/10.4274/tjh.2017.0045.
  54. Bozkurt, B.; Dayangac, M.; Tokat, Y. Living Donor Liver Transplantation. Chirurgia (Bucur) 2017, 112 (3), 217–228. https://doi.org/10.21614/chirurgia.112.3.217.
  55. Alim, A.; Tokat, Y.; Erdogan, Y.; Gokkaya, Z.; Dayangac, M.; Yuzer, Y.; Oezcelik, A. Liver Transplantation for Homozygote Familial Hypercholesterolemia: The Only Curative Treatment. Pediatr Transplant 2016, 20 (8), 1060–1064. https://doi.org/10.1111/petr.12763.
  56. Alim, A.; Erdogan, Y.; Yuzer, Y.; Tokat, Y.; Oezcelik, A. Graft-to-Recipient Weight Ratio Threshold Adjusted to the Model for End-Stage Liver Disease Score for Living Donor Liver Transplantation. Liver Transpl 2016, 22 (12), 1643–1648. https://doi.org/10.1002/lt.24523.
  57. Idilman, R.; Akyildiz, M.; Keskin, O.; Gungor, G.; Yilmaz, T. U.; Kalkan, C.; Dayangac, M.; Cinar, K.; Balci, D.; Hazinedaroglu, S.; Tokat, Y. The Long-Term Efficacy of Combining Nucleos(t)Ide Analog and Low-Dose Hepatitis B Immunoglobulin on Post-Transplant Hepatitis B Virus Recurrence. Clin Transplant 2016, 30 (10), 1216–1221. https://doi.org/10.1111/ctr.12804.
  58. Dayangac, M.; Tokat, Y. The Evolution of Anterior Sector Venous Drainage in Right Lobe Living Donor Liver Transplantation: Does One Technique Fit All? Hepatobiliary Surg Nutr 2016, 5 (2), 151–158. https://doi.org/10.3978/j.issn.2304-3881.2015.08.01.
  59. Gunay, Y.; Guler, N.; Yaprak, O.; Dayangac, M.; Akyildiz, M.; Altaca, G.; Yuzer, Y.; Tokat, Y. Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria. Indian J Surg 2015, 77 (Suppl 3), 950–956. https://doi.org/10.1007/s12262-014-1078-6.
  60. Arat, N.; Akyıldız, M.; Tellioğlu, G.; Tokat, Y. Authors’ Reply. Turk Kardiyol Dern Ars 2015, 43 (6), 586–587. https://doi.org/10.5543/tkda.2015.
  61. Oezcelik, A.; Dayangac, M.; Guler, N.; Yaprak, O.; Erdogan, Y.; Akyildiz, M.; Sevdik, Z.; Yuzer, Y.; Tokat, Y. Living Donor Liver Transplantation in Patients 70 Years or Older. Transplantation 2015, 99 (7), 1436–1440. https://doi.org/10.1097/TP.0000000000000524.
  62. Guler, N.; Yaprak, O.; Gunay, Y.; Dayangac, M.; Akyildiz, M.; Yuzer, F.; Yuzer, Y.; Tokat, Y. Major Complications of Adult Right Lobe Living Liver Donors. Hepatobiliary Pancreat Dis Int 2015, 14 (2), 150–156. https://doi.org/10.1016/s1499-3872(15)60346-0.
  63. Arat, N.; Akyıldız, M.; Tellioğlu, G.; Tokat, Y. Cardiac Involvement of Primary Hyperoxaluria Accompanied by Non-Compaction Cardiomyopathy and Patent Ductus Arteriosus. Turk Kardiyol Dern Ars 2015, 43 (3), 288–291. https://doi.org/10.5543/tkda.2015.46026.
  64. Demirbas, T.; Akyildiz, M.; Dayangac, M.; Yaprak, O.; Dogusoy, G.; Bassullu, N.; Yuzer, Y.; Tokat, Y. Living Donor Right Lobe Liver Transplantation as a Treatment for Hepatic Alveolar Echinococcosis: Report of Three Cases. Hepatogastroenterology 2015, 62 (137), 93–97.
  65. Gunay, Y.; Guler, N.; Dayangac, M.; Taskesen, F.; Yaprak, O.; Emek, E.; Akyildiz, M.; Altaca, G.; Yuzer, Y.; Tokat, Y. Living Donor Liver Transplantation for Obese Patients: Challenges and Outcomes. Liver Transpl 2014, 20 (3), 311–322. https://doi.org/10.1002/lt.23794.
  66. Gunay, Y.; Guler, N.; Akyildiz, M.; Yaprak, O.; Dayangac, M.; Yuzer, Y.; Tokat, Y. Management of Patients with Recurrent Hepatocellular Carcinoma Following Living Donor Liver Transplantation: A Single Center Experience. Gulf J Oncolog 2014, 1 (15), 12–18.
  67. Guler, N.; Unalp, O.; Guler, A.; Yaprak, O.; Dayangac, M.; Sozbilen, M.; Akyildiz, M.; Tokat, Y. Glasgow Coma Scale and APACHE-II Scores Affect the Liver Transplantation Outcomes in Patients with Acute Liver Failure. Hepatobiliary Pancreat Dis Int 2013, 12 (6), 589–593. https://doi.org/10.1016/s1499-3872-13-60093-4.
  68. Guler, N.; Dayangac, M.; Yaprak, O.; Akyildiz, M.; Gunay, Y.; Taskesen, F.; Tabandeh, B.; Bulutcu, F.; Yuzer, Y.; Tokat, Y. Anatomical Variations of Donor Portal Vein in Right Lobe Living Donor Liver Transplantation: The Safe Use of Variant Portal Veins. Transpl Int 2013, 26 (12), 1191–1197. https://doi.org/10.1111/tri.12190.
  69. Guler, N.; Gunay, Y.; Dayangac, M.; Yaprak, O.; Akyildiz, M.; Yuzer, Y.; Tokat, Y. Liver Transplantation for Fulminant Hepatic Failure Due to Iatrogenic Porta Hepatis Injury. Minerva Chir 2013, 68 (3), 333–334.
  70. Demirbas, T.; Bulutcu, F.; Dayangac, M.; Yaprak, O.; Guler, N.; Oklu, L.; Akyildiz, M.; Altaca, G.; Tokat, Y.; Yuzer, Y. Which Incision Is Better for Living-Donor Right Hepatectomy? Midline, J-Shaped, or Mercedes. Transplant Proc 2013, 45 (1), 218–221. https://doi.org/10.1016/j.transproceed.2012.06.081.
  71. Demirbas, B. T.; Piskin, T.; Dayangac, M.; Yaprak, O.; Oklu, L.; Yuzer, Y.; Tokat, Y. Successful Treatment of Severe Hepatorenal Syndrome with Living Donor Liver Transplantation. Hepatogastroenterology 2012, 59 (119), 2305–2306. https://doi.org/10.5754/hge10791.
  72. Bassullu, N.; Turkmen, I.; Dayangac, M.; Yagiz Korkmaz, P.; Yasar, R.; Akyildiz, M.; Yaprak, O.; Tokat, Y.; Yuzer, Y.; Bulbul Dogusoy, G. The Predictive and Prognostic Significance of C-Erb-B2, EGFR, PTEN, MTOR, PI3K, P27, and ERCC1 Expression in Hepatocellular Carcinoma. Hepat Mon 2012, 12 (10 HCC), e7492. https://doi.org/10.5812/hepatmon.7492.
  73. Yaprak, O.; Guler, N.; Balci, N. C.; Dayangac, M.; Demirbas, T.; Killi, R.; Tokat, Y.; Yuzer, Y. A New Technique for the Reconstruction of Complex Portal Vein Anomalies in Right Lobe Living Liver Donors. Hepatobiliary Pancreat Dis Int 2012, 11 (4), 438–441. https://doi.org/10.1016/s1499-3872-12-60205-7.
  74. Yaprak, O.; Guler, N.; Altaca, G.; Dayangac, M.; Demirbas, T.; Akyildiz, M.; Ulusoy, L.; Tokat, Y.; Yuzer, Y. Ratio of Remnant to Total Liver Volume or Remnant to Body Weight: Which One Is More Predictive on Donor Outcomes? HPB (Oxford) 2012, 14 (7), 476–482. https://doi.org/10.1111/j.1477-2574.2012.00483.x.
  75. Yaprak, O.; Akyildiz, M.; Dayangac, M.; Demirbas, B. T.; Guler, N.; Dogusoy, G. B.; Yuzer, Y.; Tokat, Y. AFP Level and Histologic Differentiation Predict the Survival of Patients with Liver Transplantation for Hepatocellular Carcinoma. Hepatobiliary Pancreat Dis Int 2012, 11 (3), 256–261. https://doi.org/10.1016/s1499-3872-12-60157-x.
  76. Piskin, T.; Demirbas, T.; Yalcin, L.; Yaprak, O.; Dayangac, M.; Guler, N.; Bulutcu, F.; Yuzer, Y.; Tokat, Y. Recipient Splenic Artery Utilization for Arterial Re-Anastomosis in Living Donor Liver Transplantation: Single-Center Experience. Hepatogastroenterology 2012, 59 (116), 1263–1264. https://doi.org/10.5754/hge11642.
  77. Akun, E.; Yaprak, O.; Killi, R.; Balci, N. C.; Tokat, Y.; Yuzer, Y. Vascular Complications in Hepatic Transplantation: Single-Center Experience in 14 Years. Transplant Proc 2012, 44 (5), 1368–1372. https://doi.org/10.1016/j.transproceed.2012.02.027.
  78. Bas, K.; Yaprak, O.; Dayangac, M.; Ulusoy, O. L.; Dogusoy, G. B.; Yuzer, Y.; Tokat, Y. Living-Donor Liver Transplant in 3 Patients with Budd-Chiari Syndrome: Case Report. Exp Clin Transplant 2012, 10 (2), 172–175. https://doi.org/10.6002/ect.2011.0044.
  79. Demirbas, T.; Piskin, T.; Dayangac, M.; Yaprak, O.; Akyildiz, M.; Tokat, Y.; Yuzer, Y. Right-Lobe Liver Transplant from Donors with Gilbert Syndrome. Exp Clin Transplant 2012, 10 (1), 39–42. https://doi.org/10.6002/ect.2011.0063.
  80. Yaprak, O.; Dayangac, M.; Akyildiz, M.; Demirbas, T.; Guler, N.; Bulutcu, F.; Bassullu, N.; Akun, E.; Yuzer, Y.; Tokat, Y. Biliary Complications after Right Lobe Living Donor Liver Transplantation: A  Single-Centre Experience. HPB (Oxford) 2012, 14 (1), 49–53. https://doi.org/10.1111/j.1477-2574.2011.00401.x.
  81. Bas, K.; Dayangac, M.; Yaprak, O.; Yuzer, Y.; Tokat, Y. International Collaboration of Turkey in Liver Transplantation Research: A Bibliometric Analysis. Transplant Proc 2011, 43 (10), 3796–3801. https://doi.org/10.1016/j.transproceed.2011.09.081.
  82. Balci, D.; Dayangac, M.; Yaprak, O.; Akin, B.; Duran, C.; Killi, R.; Yuzer, Y.; Tokat, Y. Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Single Center Analysis of Outcomes and Impact of Different Selection Criteria. Transpl Int 2011, 24 (11), 1075–1083. https://doi.org/10.1111/j.1432-2277.2011.01311.x.
  83. Yaprak, O.; Demirbas, T.; Duran, C.; Dayangac, M.; Akyildiz, M.; Tokat, Y.; Yuzer, Y. Living Donor Liver Hilar Variations: Surgical Approaches and Implications. Hepatobiliary Pancreat Dis Int 2011, 10 (5), 474–479. https://doi.org/10.1016/s1499-3872-11-60081-7.
  84. Yaprak, O.; Balci, N. C.; Dayangac, M.; Demirbas, T.; Guler, N.; Ulusoy, L.; Tokat, Y.; Yuzer, Y. Cryopreserved Aortic Quilt Plasty for One-Step Reconstruction of Multiple Hepatic Venous Drainage in Right Lobe Living Donor Liver Transplantation. Transplant Proc 2011, 43 (7), 2817–2819. https://doi.org/10.1016/j.transproceed.2011.06.064.
  85. Dayangac, M.; Taner, C. B.; Yaprak, O.; Demirbas, T.; Balci, D.; Duran, C.; Yuzer, Y.; Tokat, Y. Utilization of Elderly Donors in Living Donor Liver Transplantation: When More Is Less? Liver Transpl 2011, 17 (5), 548–555. https://doi.org/10.1002/lt.22276.
  86. Yaprak, O.; Dayangac, M.; Demirbas, B. T.; Tabendeh, B.; Yuzer, Y.; Tokat, Y. Analysis of Right Lobe Living-Liver Donor Complications: A Single Center Experience. Exp Clin Transplant 2011, 9 (1), 56–59.
  87. Umut Ozcan, M.; Ocal, S.; Basdogan, C.; Dogusoy, G.; Tokat, Y. Characterization of Frequency-Dependent Material Properties of Human Liver and Its Pathologies Using an Impact Hammer. Med Image Anal 2011, 15 (1), 45–52. https://doi.org/10.1016/j.media.2010.06.010.
  88. Başsüllü, N.; Türkmen, I.; Yaprak, O.; Dayangaç, M.; Demırbaş, T.; Güler, N.; Uraz, S.; Akyildiz, M.; Cığercıoğullari, E.; Tokat, Y.; Yüzer, Y.; Doğusoy, G. B. General Evaluation of Hepatectomy and Hepatocellular Carcinoma Cases. Turk Patoloji Derg 2011, 27 (3), 221–229. https://doi.org/10.5146/tjpath.2011.01079.
  89. Dayangac, M.; Taner, C. B.; Akin, B.; Uraz, S.; Balci, D.; Duran, C.; Ayanoglu, O.; Killi, R.; Yuzer, Y.; Tokat, Y. Dual Left Lobe Living Donor Liver Transplantation Using Donors Unacceptable for Right Lobe Donation: A Case Report. Transplant Proc 2010, 42 (10), 4560–4563. https://doi.org/10.1016/j.transproceed.2010.09.149.
  90. Yaprak, O.; Dayangac, M.; Balci, D.; Demirbas, T.; Yuzer, Y.; Tokat, Y. Use of Livers from Hepatitis B Core Antibody Positive Donors in Living Donor Liver Transplantation. Hepatogastroenterology 2010, 57 (102–103), 1268–1271.
  91. Yaprak, O.; Dayangac, M.; Balci, D.; Bas, K.; Yuzer, Y.; Tokat, Y. Hepatitis B Prophylaxis in Living Donor Liver Transplantation: Single Center Experience. Hepatogastroenterology 2010, 57 (102–103), 1178–1182.
  92. Dayangac, M.; Taner, C. B.; Balci, D.; Memi, I.; Yaprak, O.; Akin, B.; Duran, C.; Killi, R.; Ayanoglu, O.; Yuzer, Y.; Tokat, Y. Use of Middle Hepatic Vein in Right Lobe Living Donor Liver Transplantation. Transpl Int 2010, 23 (3), 285–291. https://doi.org/10.1111/j.1432-2277.2009.00978.x.
  93. Duran, C.; Uraz, S.; Kantarci, M.; Ozturk, E.; Doganay, S.; Dayangac, M.; Bozkurt, M.; Yuzer, Y.; Tokat, Y. Hepatic Arterial Mapping by Multidetector Computed Tomographic Angiography in Living Donor Liver Transplantation. J Comput Assist Tomogr 2009, 33 (4), 618–625. https://doi.org/10.1097/RCT.0b013e31818d814b.
  94. Taner, C. B.; Dayangac, M.; Akin, B.; Balci, D.; Uraz, S.; Duran, C.; Killi, R.; Ayanoglu, O.; Yuzer, Y.; Tokat, Y. Donor Safety and Remnant Liver Volume in Living Donor Liver Transplantation. Liver Transpl 2008, 14 (8), 1174–1179. https://doi.org/10.1002/lt.21562.
  95. Balci, D.; Taner, B.; Dayangac, M.; Akin, B.; Yaprak, O.; Duran, C.; Uraz, S.; Hayzaran, S.; Ayanoglu, O.; Killi, R.; Senturk, H.; Yuzer, Y.; Tokat, Y. Splenic Abscess after Splenic Artery Ligation in Living Donor Liver Transplantation:  A Case Report. Transplant Proc 2008, 40 (5), 1786–1788. https://doi.org/10.1016/j.transproceed.2007.10.012.
  96. Sirvanci, M.; Duran, C.; Ozturk, E.; Balci, D.; Dayangaç, M.; Onat, L.; Yüzer, Y.; Tokat, Y.; Killi, R. The Value of Magnetic Resonance Cholangiography in the Preoperative Assessment of Living Liver Donors. Clin Imaging 2007, 31 (6), 401–405. https://doi.org/10.1016/j.clinimag.2007.05.003.
  97. Duran, C.; Taner, B.; Dayangac, M.; Akin, B.; Balci, D.; Kurt, Z.; Killi, R.; Yuzer, Y.; Tokat, Y. Why We Did Not Use This Donor. Liver Transpl 2007, 13 (8), 1199–1200. https://doi.org/10.1002/lt.21140.
  98. Uraz, S.; Duran, C.; Balci, D.; Akin, B.; Dayangac, M.; Kurt, Z.; Ayanoglu, O. H.; Killi, R.; Yuzer, Y.; Tokat, Y. A Very Rare Venous Anomaly in a Living Liver Donor: Left Hepatic Venous Connection to the Right Atrium. Transplant Proc 2007, 39 (5), 1714–1715. https://doi.org/10.1016/j.transproceed.2006.11.009.
  99. Celebi Kobak, A.; Karasu, Z.; Kilic, M.; Ozacar, T.; Tekin, F.; Gunsar, F.; Ersoz, G.; Yuzer, Y.; Tokat, Y. Living Donor Liver Transplantation from Hepatitis B Core Antibody Positive Donors. Transplant Proc 2007, 39 (5), 1488–1490. https://doi.org/10.1016/j.transproceed.2006.11.015.
  100. Karasu, Z.; Akyildiz, M.; Zeytunlu, M.; Noyan, A.; Yuzer, Y.; Tokat, Y.; Kilic, M. Urgent Adult-to-Adult Right Lobe Living Donor Liver Transplantation for Acute Liver Failure; a Single Center Experience from Turkey. Hepatogastroenterology 2007, 54 (75), 810–813.
  101. Duran, C.; Aydinli, B.; Tokat, Y.; Yuzer, Y.; Kantarci, M.; Akgun, M.; Polat, K. Y.; Unal, B.; Killi, R.; Atamanalp, S. S. Stereological Evaluation of Liver Volume in Living Donor Liver Transplantation Using MDCT via the Cavalieri Method. Liver Transpl 2007, 13 (5), 693–698. https://doi.org/10.1002/lt.21132.
  102. Colak, Y.; Karasu, Z.; Oruc, N.; Can, C.; Balým, Z.; Akarca, U.; Gunsar, F.; Ersoz, G.; Tokat, Y.; Batur, Y. Hyperhomocysteinaemia and Factor V Leiden Mutation Are Associated with Budd-Chiari Syndrome. Eur J Gastroenterol Hepatol 2006, 18 (8), 917–920. https://doi.org/10.1097/00042737-200608000-00019.
  103. Atamaz, F.; Hepguler, S.; Karasu, Z.; Kilic, M.; Tokat, Y. The Prevention of Bone Fractures after Liver Transplantation: Experience with Alendronate Treatment. Transplant Proc 2006, 38 (5), 1448–1452. https://doi.org/10.1016/j.transproceed.2006.02.074.
  104. Oruc, N.; Tokat, Y.; Killi, R.; Tombuloglu, M.; Ilter, T. Budd-Chiari Syndrome in an Afibrinogenemic Patient: A Paradoxical Complication. Dig Dis Sci 2006, 51 (2), 378–380. https://doi.org/10.1007/s10620-006-3141-z.
  105. Arikan, C.; Kilic, M.; Nart, D.; Ozgenc, F.; Ozkan, T.; Tokat, Y.; Yagci, R. V.; Aydogdu, S. Hepatocellular Carcinoma in Children and Effect of Living-Donor Liver Transplantation on Outcome. Pediatr Transplant 2006, 10 (1), 42–47. https://doi.org/10.1111/j.1399-3046.2005.00395.x.
  106. Aydogdu, S.; Arikan, C.; Kilic, M.; Ozgenc, F.; Akman, S.; Unal, F.; Yagci, R. V.; Tokat, Y. Outcome of Pediatric Liver Transplant Recipients in Turkey: Single Center Experience. Pediatr Transplant 2005, 9 (6), 723–728. https://doi.org/10.1111/j.1399-3046.2005.00366.x.
  107. Ilkgul, O.; Kilic, M.; Içöz, G.; Zeytunlu, M.; Demirpolat, G.; Akyildiz, M.; Tokat, Y.; Parildar, M.; Memis, A. Experience with Mesocaval Shunt with Autologous Jugular Vein Interposition in Patients with Budd-Chiari Syndrome. Hepatogastroenterology 2005, 52 (63), 662–665.
  108. Akay, S.; Karasu, Z.; Akyildiz, M.; Tokat, Y.; Goker, E. Successful Treatment of Liver Transplant-Associated Kaposi’s Sarcoma with Long-Term Vincristine. Transplant Proc 2005, 37 (5), 2188–2189. https://doi.org/10.1016/j.transproceed.2005.03.024.
  109. Karasu, Z.; Ozacar, T.; Akarca, U.; Ersoz, G.; Erensoy, S.; Gunsar, F.; Kobat, A.; Tokat, Y.; Batur, Y. HBV Vaccination in Liver Transplant Recipients: Not an Effective Strategy in the Prophylaxis of HBV Recurrence. J Viral Hepat 2005, 12 (2), 212–215. https://doi.org/10.1111/j.1365-2893.2005.00585.x.
  110. Inceboz, T.; Korkmaz, M.; Tokat, Y.; Uner, A. The First Report of Echinococcus Multilocularis Strain Isolation from Human in Turkey. Turkiye Parazitol Derg 2005, 29 (1), 31–33.
  111. Idilman, R.; Erden, E.; Kuzu, I.; Ersoz, S.; Karasu, Z.; Karayalcin, K.; Yuce, G.; Tokat, Y.; Sahin, Y.; Tukun, A.; Akarca, U. S.; Karayalcin, S. Recipient-Derived Hepatocytes in Sex-Mismatched Liver Allografts after Liver Transplantation: Early versus Late Transplant Biopsies. Transplantation 2004, 78 (11), 1647–1652. https://doi.org/10.1097/01.tp.0000144055.78462.4f.
  112. Karasu, Z.; Ozacar, T.; Akyildiz, M.; Demirbas, T.; Arikan, C.; Kobat, A.; Akarca, U.; Ersoz, G.; Gunsar, F.; Batur, Y.; Kilic, M.; Tokat, Y. Low-Dose Hepatitis B Immune Globulin and Higher-Dose Lamivudine Combination to Prevent Hepatitis B Virus Recurrence after Liver Transplantation. Antivir Ther 2004, 9 (6), 921–927.
  113. Arikan, C.; Ozgenc, F.; Akman, S. A.; Kilic, M.; Tokat, Y.; Yagci, R. V.; Aydogdu, S. Impact of Liver Transplantation on Renal Function of Patients with Congenital Hepatic Fibrosis Associated with Autosomal Recessive Polycystic Kidney Disease. Pediatr Transplant 2004, 8 (6), 558–560. https://doi.org/10.1111/j.1399-3046.2004.00224.x.
  114. Orguc, S.; Tercan, M.; Bozoklar, A.; Akyildiz, M.; Gurgan, U.; Celebi, A.; Nart, D.; Karasu, Z.; Icoz, G.; Zeytunlu, M.; Yuzer, Y.; Tokat, Y.; Kilic, M. Variations of Hepatic Veins: Helical Computerized Tomography Experience in 100 Consecutive Living Liver Donors with Emphasis on Right Lobe. Transplant Proc 2004, 36 (9), 2727–2732. https://doi.org/10.1016/j.transproceed.2004.10.006.
  115. Karasu, Z.; Ulukaya, S.; Ayanoglu, H. O.; Basturk, B.; Ulukaya, E.; Akyildiz, M.; Tokat, Y. Cytokine Gene Polymorphism and Early Graft Rejection in Liver Transplant Recipients. Transplant Proc 2004, 36 (9), 2791–2795. https://doi.org/10.1016/j.transproceed.2004.10.034.
  116. Akay, S.; Karasu, Z.; Akyildiz, M.; Tokat, Y. Adefovir Treatment in Posttransplant Hepatitis B Virus Infection Resistant to Lamivudine plus Hepatitis B Virus Immunoglobulin. Transplant Proc 2004, 36 (9), 2768–2770. https://doi.org/10.1016/j.transproceed.2004.09.062.
  117. Ilkgül, O.; Içöz, G.; Dayangaç, M.; Tokat, Y.; Ozütemiz, O. A Case of Antiphospholipid Antibody Syndrome with Budd-Chiari and Colonic Ulcers Complicated with Gastrointestinal Hemorrhage. Turk J Gastroenterol 2004, 15 (2), 115–116.
  118. Akyildiz, M.; Karasu, Z.; Cagirgan, S.; Kilic, M.; Tokat, Y. Rituximab Therapy for Life-Threatining Immune Hemolytic Anemia in a Liver Tranplant Recipient: A Case Report. Transplant Proc 2004, 36 (5), 1492–1493. https://doi.org/10.1016/j.transproceed.2004.05.042.
  119. Akyildiz, M.; Karasu, Z.; Arikan, C.; Kilic, M.; Zeytunlu, M.; Gunsar, F.; Ersoz, G.; Akarca, U.; Batur, Y.; Tokat, Y. Impact of Pretransplant MELD Score on Posttransplant Outcome in Living Donor Liver Transplantation. Transplant Proc 2004, 36 (5), 1442–1444. https://doi.org/10.1016/j.transproceed.2004.05.004.
  120. Ozgenç, F.; Aydoğdu, S.; Aksoylar, S.; Elmas, N.; Yüce, G.; Yağci, R. V.; Tokat, Y. Regenerative Nodule Mimicking Hepatocellular Carcinoma in a Cirrhotic Child Due to Hepatitis B: An Imaging Dilemma. Pediatr Transplant 2004, 8 (2), 198–200. https://doi.org/10.1046/j.1399-3046.2003.00019.x.
  121. Aydoğdu, S.; Ozgenç, F.; AtIk, T.; Unal, F.; Tokat, Y.; Yagci, R. V. Biliary Atresia in Turkish Children. Pediatr Int 2004, 46 (2), 158–161. https://doi.org/10.1046/j.1442-200x.2004.01875.x.
  122. Kara, E.; Gökhan, I.; Dayangaç, M.; Ilkgül, O.; Ertan, H.; Tokat, Y.; Terzioglu, E. Effect of Portal Venous Injection of Donor Spleen Cells on Skin Allograft Survival in Rat. Indian J Med Res 2004, 119 (3), 110–114.
  123. Nart, D.; Arikan, C.; Akyildiz, M.; Yuce, G.; Demirpolat, G.; Zeytunlu, M.; Karasu, Z.; Aydogdu, S.; Killi, R.; Yuzer, Y.; Tokat, Y.; Kilic, M. Hepatocellular Carcinoma in Liver Transplant Era: A Clinicopathologic Analysis. Transplant Proc 2003, 35 (8), 2986–2990. https://doi.org/10.1016/j.transproceed.2003.10.076.
  124. Karasu, Z.; Nart, D.; Lebe, E.; Demirbas, T.; Memis, A.; Kilic, M.; Akyildiz, M.; Tokat, Y. Liver Transplantation in a Patient with Budd-Chiari Syndrome Secondary to Factor V Leiden Mutation. Transplant Proc 2003, 35 (8), 3008–3010. https://doi.org/10.1016/j.transproceed.2003.10.038.
  125. Aydoğdu, S.; Ozgenç, F.; Yurtsever, S.; Akman, S. A.; Tokat, Y.; Yağci, R. V. Our Experience with Fulminant Hepatic Failure in Turkish Children: Etiology and Outcome. J Trop Pediatr 2003, 49 (6), 367–370. https://doi.org/10.1093/tropej/49.6.367.
  126. Ayanoglu, H. O.; Ulukaya, S.; Yuzer, Y.; Tokat, Y. Anesthetic Management and Complications in Living Donor Hepatectomy. Transplant Proc 2003, 35 (8), 2970–2973. https://doi.org/10.1016/j.transproceed.2003.10.090.
  127. Arikan, C.; Tekgul, H.; Eğilmez, S.; Kilic, M.; Yagci, R. V.; Tokat, Y.; Aydogdu, S. Stage IV Hepatic Encephalopathy Associated with Acute Blindness after Liver Transplantation. Pediatr Transplant 2003, 7 (6), 497–500. https://doi.org/10.1046/j.1397-3142.2003.00118.x.
  128. Arikan, C.; Kilic, M.; Tokat, Y.; Aydogdu, S. Allergic Disease after Pediatric Liver Transplantation with Systemic Tacrolimus and Cyclosporine a Therapy. Transplant Proc 2003, 35 (8), 3039–3041. https://doi.org/10.1016/j.transproceed.2003.10.033.
  129. Ulukaya, S.; Arikan, C.; Aydogdu, S.; Ayanoglu, H. O.; Tokat, Y. Immediate Tracheal Extubation of Pediatric Liver Transplant Recipients in the Operating Room. Pediatr Transplant 2003, 7 (5), 381–384. https://doi.org/10.1034/j.1399-3046.2003.00072.x.
  130. Arikan, C.; Ozgenç, F.; Akman, S. A.; Yağci, R. V.; Tokat, Y.; Aydoğdu, S. Large-Volume Paracentesis and Liver Transplantation. J Pediatr Gastroenterol Nutr 2003, 37 (2), 207–208. https://doi.org/10.1097/00005176-200308000-00025.
  131. Zeytunlu, M.; Icoz, G.; Kiliç, M.; Demirbas, T.; Tokat, Y.; Yuzer, Y. Donor Safety in Adult-to-Adult Living Donor Liver Transplantation. Transplant Proc 2003, 35 (4), 1430–1432. https://doi.org/10.1016/s0041-1345-03-00465-2.
  132. Karasu, Z.; Kilic, M.; Cagirgan, S.; Lebe, E.; Yilmaz, F.; Demirbas, T.; Tokat, Y. Hemophagocytic Syndrome after Living-Related Liver Transplantation. Transplant Proc 2003, 35 (4), 1482–1484. https://doi.org/10.1016/s0041-1345-03-00511-6.
  133. Icoz, G.; Kilic, M.; Zeytunlu, M.; Celebi, A.; Ersoz, G.; Killi, R.; Memis, A.; Karasu, Z.; Yuzer, Y.; Tokat, Y. Biliary Reconstructions and Complications Encountered in 50 Consecutive Right-Lobe Living Donor Liver Transplantations. Liver Transpl 2003, 9 (6), 575–580. https://doi.org/10.1053/jlts.2003.50129.
  134. Icoz, G.; Kilic, M.; Zeytunlu, M.; Yaprak, O.; Arikan, C.; Yuzer, Y.; Tokat, Y. Roux-En-Y Bleeding after Living Donor Liver Transplantation: A Novel Technique for  Surgical Treatment. Transplant Proc 2003, 35 (4), 1463–1465. https://doi.org/10.1016/s0041-1345-03-00484-6.
  135. Ayanoglu, H. O.; Ulukaya, S.; Tokat, Y. Causes of Postreperfusion Syndrome in Living or Cadaveric Donor Liver Transplantations. Transplant Proc 2003, 35 (4), 1442–1444. https://doi.org/10.1016/s0041-1345-03-00483-4.
  136. Zeytunlu, M.; Icoz, G.; Kiliç, M.; Yuzer, Y.; Tokat, Y. Optimal Venous Drainage for Right Lobe Living Donor Liver Grafts. Transplant Proc 2002, 34 (8), 3327–3330. https://doi.org/10.1016/s0041-13450203674-6.
  137. Ulukaya, S.; Ayanoglu, H. O.; Acar, L.; Tokat, Y.; Kilic, M. Immediate Tracheal Extubation of the Liver Transplant Recipients in the Operating  Room. Transplant Proc 2002, 34 (8), 3334–3335. https://doi.org/10.1016/s0041-13450203670-9.
  138. Cavusoglu, C.; Cicek-Saydam, C.; Karasu, Z.; Karaca, Y.; Ozkahya, M.; Toz, H.; Tokat, Y.; Bilgic, A. Mycobacterium Tuberculosis Infection and Laboratory Diagnosis in Solid-Organ  Transplant Recipients. Clin Transplant 2002, 16 (4), 257–261. https://doi.org/10.1034/j.1399-0012.2002.01098.x.
  139. Günşar, F.; Aydin, A.; Tokat, Y.; Elmas, N. Idiopathic Hepatocellular Adenoma with Intratumoral Haemorrhage. Eur J Gastroenterol Hepatol 2002, 14 (4), 463–464. https://doi.org/10.1097/00042737-200204000-00024.
  140. Tokat, Y.; Yuzer, Y.; Karasu, Z.; Alper, M.; Killi, R.; Zeytunlu, M.; Yilmaz, F. New Frontiers: Adult to Adult Living Donor Liver Transplantation, Single Center  Experience from Turkey. Transplant Proc 2001, 33 (7–8), 3458–3460. https://doi.org/10.1016/s0041-13450102490-3.
  141. Yağdi, T.; Büket, S.; Tokat, Y.; Posacioglu, H.; Aşkar, F. Circulatory Arrest to Protect Transplant Kidney in a Patient with Chronic Type III Dissection. Ann Vasc Surg 2001, 15 (5), 575–577. https://doi.org/10.1007/s10016-001-0008-9.
  142. Sayiner, A.; Ece, T.; Duman, S.; Yildiz, A.; Ozkahya, M.; Kiliçaslan, Z.; Tokat, Y. Tuberculosis in Renal Transplant Recipients. Transplantation 1999, 68 (9), 1268–1271. https://doi.org/10.1097/00007890-199911150-00009.
  143. Ok, E.; Unsal, A.; Celik, A.; Zeytinoğlu, A.; Ersöz, G.; Tokat, Y.; Erensoy, S.; Akarca, U. S.; Basçi, A.; Yüce, G. Clinicopathological Features of Rapidly Progressive Hepatitis C Virus Infection in HCV Antibody Negative Renal Transplant Recipients. Nephrol Dial Transplant 1998, 13 (12), 3103–3107. https://doi.org/10.1093/ndt/13.12.3103.
  144. Uslu, A.; Tokat, Y.; Ok, E.; Unsal, A.; Celik, A.; Yalaz, S.; Kaplan, H. Impact of Extreme Donor Age on the Outcome of Living-Related Donor Kidney  Transplantation. Transplant Proc 1998, 30 (3), 734–737. https://doi.org/10.1016/s0041-13459800028-1.
  145. Yararbai, O.; Osmanodlu, H.; Kaplan, H.; Tokat, Y.; Coker, A.; Korkut, M.; Kapkac, M. Esophagocoloplasty in the Management of Postcorrosive Strictures of the Esophagus. Hepatogastroenterology 1998, 45 (19), 59–64.
  146. Uslu, A.; Tokat, Y.; Ok, E.; Unsal, A.; Ilkgul, O.; Kaplan, H. ATG versus OKT3 in the Treatment of Steroid-Resistant Rejection Following Living-Related Donor Renal Transplantation. Transplant Proc 1997, 29 (7), 2805–2806. https://doi.org/10.1016/s0041-13459700686-6.
  147. Tokat, Y.; Uslu, A.; Ok, E.; Tunçyürek, P.; Celik, A.; Yararbaş, O. Surgical Management of Vesicoureteral Reflux Following Renal Transplantation. Transplant Proc 1997, 29 (7), 3073–3074. https://doi.org/10.1016/s0041-13459700787-2.
  148. Kürşat, S.; Cağirgan, S.; Ok, E.; Unsal, A.; Tokat, Y.; Saydam, G.; Akçiçek, F.; Başçi, A. Haemophagocytic-Histiocytic Syndrome in Renal Transplantation. Nephrol Dial Transplant 1997, 12 (5), 1058–1060. https://doi.org/10.1093/ndt/12.5.1058.
  149. Kurşat, S.; Ok, E.; Zeytinoglu, A.; Tokat, Y.; Saydam, G.; Cirit, M.; Akçiçek, F. Nocardiosis in Renal Transplant Patients. Nephron 1997, 75 (3), 370–371. https://doi.org/10.1159/000189570.
  150. Cagirgan, S.; Cirit, M.; Ok, E.; Sencan, M.; Hekimgil, M.; Unsal, A.; Saydam, G.; Tokat, Y. Castleman’s Disease in a Renal Allograft Recipient. Nephron 1997, 76 (3), 352–353. https://doi.org/10.1159/000190204.
  151. Tokat, Y.; Zeytunlu, M.; Kilic, M.; Kaplan, H.; Yararbaş, O. Gastrointestinal Complications in Renal Transplantation. Transplant Proc 1996, 28 (4), 2351–2352.
  152. Tokat, Y.; Kiliç, M.; Kürşat, S.; Ok, E.; Sayiner, A.; Tanil, V.; Başçi, A. Tuberculosis after Renal Transplantation. Transplant Proc 1996, 28 (4), 2353–2354.
  153. Soin, A. S.; Friend, P. J.; Rasmussen, A.; Saxena, R.; Tokat, Y.; Alexander, G. J.; Jamieson, N. V.; Calne, R. Y. Donor Arterial Variations in Liver Transplantation: Management and Outcome of 527 Consecutive Grafts. Br J Surg 1996, 83 (5), 637–641. https://doi.org/10.1002/bjs.1800830515.
  154. Ok, E.; Akcicek, F.; Toz, H.; Coker, A.; Kursat, S.; Tokat, Y.; Arac, N. Goitre and Severe Autonomic Neuropathy Due to Secondary Amyloidosis in a Renal Transplant Patient. Clin Nephrol 1996, 45 (5), 361–362.
  155. Ok, E.; Kursat, S.; Tokat, Y.; Cirit, M.; Tombuloglu, M.; Akcicek, F. The Reproducibility of Cyclosporin-Induced Hemolytic Uremic Syndrome in a Renal  Allograft Recipient. Nephron 1996, 74 (1), 238. https://doi.org/10.1159/000363081.
  156. Ok, E.; Kursat, S.; Alev, M.; Tobu, M.; Tokat, Y.; Akcicek, F.; Hoscoskun, C.; Basci, A. Further Evidence of Favorable Effects of Gemfibrozil on the Lipid Profile in Renal Allograft Recipients. Nephron 1996, 73 (3), 491–492. https://doi.org/10.1159/000189121.
  157. Saxena, R.; Tokat, Y.; Rasmussen, A.; Jamieson, N. V.; Calne, R. Segmental Arteries to Segments I-IV from the Common Hepatic Artery. Br J Surg 1995, 82 (6), 817–818. https://doi.org/10.1002/bjs.1800820631.
  158. Tokat, Y.; Soin, A.; Saxena, R.; Watson, C. J.; Rasmussen, A.; Sakurada, M.; Wight, D.; Friend, P. J.; Jamieson, N. V.; Calne, R. Y. Posttransplant Problems Requiring Regrafting: An Analysis of 72 Patients with 96 Liver Retransplants. Transplant Proc 1995, 27 (1), 1264–1265.
  159. Soin, A. S.; Rasmussen, A.; Jamieson, N. V.; Tokat, Y.; Watson, C. J.; Friend, P. J.; Wight, D. G.; Calne, R. Y. Cyclosporine Levels in the Early Posttransplant Period: Predictive of Chronic Rejection in Liver Transplantation? Transplant Proc 1995, 27 (1), 1129–1130.
  160. Saxena, R.; Tokat, Y.; Soin, A. S.; Rasmussen, A.; Jamieson, N. V.; Calne, R. Relationship between Patterns of Hepatobiliary Vascular Supply and Biliary Complications in Liver Transplantation: An Anatomical and Clinical Analysis. Transplant Proc 1995, 27 (1), 1199–1200.
  161. Chávez-Cartaya, R.; Rasmussen, A.; Tokat, Y.; Jamieson, N. V. Effect of Preservation Time on Early Graft Function and Outcome of Orthotopic Liver Transplants. Transplant Proc 1995, 27 (1), 724–726.
  162. Ok, E.; Akcicek, F.; Coker, A.; Tombuloğlu, M.; Toz, H.; Tokat, Y.; Cirit, M.; Tobu, M.; Onder, G.; Basci, A. Alloimmune Haemolytic Anaemia after Renal Transplantation. Nephrol Dial Transplant 1995, 10 (3), 404–405.
  163. Coker, A.; Ok, E.; Tokat, Y.; Hoşcoşkun, C.; Kaplan, H.; Yararbaş, O. Evaluation of Patients Transplanted in Countries Other than Turkey. Transplant Proc 1994, 26 (4), 2455–2456.
  164. Tokat, Y.; Coker, A.; Basci, A.; Hoscoskun, C.; Kaplan, H.; Yararbas, O. Is Mezlocilline Prophylaxis Effective in Clinical Renal Transplantation? Transplant Proc 1992, 24 (5), 1757.
  165. Karacan, I.; Moore, C. A.; Hirshkowitz, M.; Sahmay, S.; Narter, E. M.; Tokat, Y.; Tuncel, L. Uterine Activity during Sleep. Sleep 1986, 9 (3), 393–398. https://doi.org/10.1093/sleep/9.3.393.

İletişim Bilgileri

+90 212 266 7580

+90 555 156 72 76

info@ilcistanbul.com

Yol tarifi için tıklayın.

Fulya Mah. Yeşilçimen Sk.
Polat Residence No: 12/407
Şişli, İstanbul, TURKEY

Mesaj Yazın

Lütfen adınızı ve soyadınızı yazınız.
Lütfen telefonunuzu yazınız.
Lütfen e-posta adresinizi yazınız.
Lütfen mesajınızı yazınız.

Please publish modules in offcanvas position.